Alvea launches trials of shelf-stable DNA vaccine against new SARS-CoV-2 variants

Alvea launches trials of shelf-stable DNA vaccine against new SARS-CoV-2 variants

Submitted by admin on February 17, 2022 - 10:50am
Source: 
Biopharma Reporter
News Tags: 
Alvea
vaccines
DNA
COVID-19
COVID-19 variants clinical trials
Headline: 
Alvea launches trials of shelf-stable DNA vaccine against new SARS-CoV-2 variants
snippet: 

Start-up biotech Alvea has started pre-clinical testing for its DNA vaccine: with clinical trials set to begin as soon as March.

Do Not Allow Advertisers to Use My Personal information